| |
| |
|
| Insider
Information: |
Bell Leonard |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
390,670 |
|
|
Indirect Shares
|
403,285 |
|
|
| Direct
Value |
$71,297,275 |
|
|
|
Indirect Value
|
$73,599,513 |
|
|
| Total
Shares |
793,955 |
|
|
| Total
Value |
$144,896,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-03-01 |
390,670 |
2017-01-09 |
403,285 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
283 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 9 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-08-30 |
4 |
AS |
$109.92 |
$54,960 |
D/D |
(500) |
1,034,177 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-08-29 |
4 |
AS |
$109.93 |
$218,981 |
D/D |
(1,992) |
1,034,677 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-09-04 |
4 |
AS |
$110.07 |
$203,630 |
D/D |
(1,850) |
1,001,669 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-09-03 |
4 |
AS |
$110.15 |
$3,378,890 |
D/D |
(30,658) |
1,003,519 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-09-28 |
4 |
AS |
$111.44 |
$8,480,584 |
D/D |
(76,100) |
1,672,114 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-09-27 |
4 |
AS |
$111.96 |
$7,542,011 |
D/D |
(67,000) |
1,632,550 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-09-16 |
4 |
AS |
$115.00 |
$402,500 |
D/D |
(3,500) |
1,026,293 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-10-01 |
4 |
AS |
$115.26 |
$2,082,946 |
D/D |
(18,070) |
1,681,834 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-08-05 |
4 |
S |
$116.87 |
$341,144 |
D/D |
(2,919) |
1,176,669 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-12-18 |
4 |
AS |
$123.35 |
$17,569,149 |
D/D |
(140,000) |
1,031,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-02-06 |
4 |
S |
$125.69 |
$969,728 |
D/D |
(7,715) |
395,904 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-02-09 |
4 |
S |
$126.84 |
$31,203 |
D/D |
(246) |
394,648 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-02-07 |
4 |
S |
$128.09 |
$129,371 |
D/D |
(1,010) |
394,894 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-12-19 |
4 |
AS |
$129.90 |
$4,546,500 |
D/D |
(35,000) |
1,031,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-02-28 |
4 |
S |
$131.71 |
$360,622 |
D/D |
(2,738) |
391,910 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-03-01 |
4 |
S |
$132.50 |
$164,300 |
D/D |
(1,240) |
390,670 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-29 |
4 |
S |
$133.72 |
$355,929 |
D/D |
(2,660) |
975,066 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-01-05 |
4 |
AS |
$134.90 |
$91,783 |
I/I |
(668) |
403,619 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-08 |
4 |
AS |
$134.93 |
$865,036 |
D/D |
(6,411) |
1,031,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-10 |
4 |
AS |
$135.00 |
$1,580,175 |
D/D |
(11,705) |
1,031,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-09 |
4 |
AS |
$135.05 |
$140,317 |
D/D |
(1,039) |
1,031,957 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-01-05 |
4 |
AS |
$135.07 |
$4,704,730 |
D/D |
(34,210) |
404,287 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-01-13 |
4 |
AS |
$135.25 |
$2,143,036 |
D/D |
(15,845) |
1,043,662 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2016-10-31 |
4 |
AS |
$135.28 |
$175,864 |
D/D |
(1,300) |
405,289 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2016-10-31 |
4 |
AS |
$135.37 |
$45,214 |
I/I |
(334) |
404,955 |
0 |
- |
|
283 Records found
|
|
Page 9 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
